Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual
WALTHAM, Mass., Sept. 3, 2013
WALTHAM, Mass., Sept. 3, 2013 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global
leader in enabling individuals to take charge of their health at home through
the merger of rapid diagnostics and health management, has declared a cash
dividend of $3.00 per share on its Series B Convertible Perpetual Preferred
Stock (NYSE: ALR.PR.B). The dividend is payable on October 15, 2013 to
holders of record of Series B stock at the close of business on October 1,
Such payment will cover the amount of all dividends accrued from July 1, 2013
through September 30, 2013.
For more information about Alere, please visit our website at
By developing new capabilities in near-patient diagnosis, monitoring and
health information solutions, Alere enables individuals to take charge of
improving their health and quality of life at home. Alere's global leading
products and services, as well as its new product development efforts, focus
on cardiology, infectious disease, toxicology and diabetes. Alere is
headquartered in Waltham, Massachusetts.
SOURCE Alere Inc.
Contact: Doug Guarino, Director of Corporate Relations, 781-647-3900; Jon
Russell, Vice President of Finance
Press spacebar to pause and continue. Press esc to stop.